Veterans' Support Regulations 2014

  • not the latest version

2014/369

Coat of Arms of New Zealand

Veterans' Support Regulations 2014

Jerry Mateparae, Governor-General

Order in Council

At Wellington this 1st day of December 2014

Present:
The Right Hon John Key presiding in Council

Pursuant to sections 7, 20, 21, 22, 31, 47, 56, 66, 72, 76, 81, 145, 148, 151, 153, 154, 169, 174, 229, 247, 254, 265, 266, and 269 of the Veterans’ Support Act 2014, His Excellency the Governor-General makes the following regulations, acting—

  • (a) on the advice and with the consent of the Executive Council; and

Contents

1 Title

2 Commencement

3 Interpretation

Part 1
Regulations relating to Part 1 of Act

Treatment providers

4 Additional occupational groups to be treatment providers

5 Acupuncturists

6 Audiologists

7 Counsellors

8 Speech therapists

Paired organs

9 Paired organs

Illnesses and conditions conclusively presumed to be service-related

10 Conclusively presumed illnesses and conditions

11 World War II prisoners of war

12 Exposure to nuclear radiation

13 Vietnam

14 Gulf War

Statements of principles

15 Certain Australian statements of principles apply

Indexation of entitlements

16 Formula for indexation of certain entitlements under section 31 of Act

Part 2
Regulations relating to Part 3 of Act

Rate of disablement pension

17 Rate of disablement pension

Surviving spouse or partner pension

18 Rate of surviving spouse or partner pension

Children’s pension

19 Rate of children’s pension

Dependant’s pension

20 Maximum rate of dependant’s pension

21 VANZ to take into account dependant’s economic position in determining actual rate

22 Rate of dependant’s pension

23 Dependant’s income

24 Deprivation of assets and income

25 How value of land to be determined

Children’s bursaries

26 Rates of children’s bursaries

Part 3
Regulations relating to Part 5 of Act

Weekly battery allowance

27 Entitlement to weekly battery allowance

28 Rate of weekly battery allowance

Motor vehicle grants

29 Interpretation

30 Maximum amount of grant

31 Frequency of grants

32 Additional grant for fitting controls

33 Criteria for determining whether to make grant

Retirement lump sums

34 Amount of retirement lump sum

35 Asset threshold for non-exempt assets

36 Assets to be included in asset assessment

37 Deprivation of assets

38 Gifting period

39 How value of land to be determined

Funeral expenses

40 Funeral expenses

41 Cost of transport of veteran’s body

Part 4
Regulations relating to Part 6 of Act

Rates of veteran’s pension

42 Rates of veteran’s pension

Lump sum payment on death

43 Lump sum payment on death of veteran

44 Lump sum payment on death of spouse or partner of veteran

Part 5
Regulations relating to Part 7 of Act

45 Procedure for appeals against review decisions

46 Interpretation

47 VANZ must advise applicant of right to appeal

48 Notice of appeal

49 Notice of hearing

50 Case management conferences and directions

51 Evidence

52 Appellant not giving oral evidence

53 Appeal may continue on death of veteran or other claimant

Part 6
Regulations relating to Part 8 of Act

Procedure of Veterans’ Advisory Board and Veterans’ Health Advisory Panel

54 Interpretation

Meetings

55 Notice of meetings

56 Methods of holding meetings

57 Unanimous written resolutions

Disclosure of interests

58 Obligation to disclose interest

59 Who disclosure of interests must be made to

60 What must be disclosed

61 Consequences of being interested in matter

62 Consequences of failing to disclose interest

63 Permission to act despite being interested in matter

Part 7
Regulations relating to Part 9 of Act

Treatment cards

64 Issue of treatment card

65 Information to be included on treatment card

66 Obligations of treatment card holders

67 Conditions of use

68 Unauthorised uses of treatment card

69 Recall of treatment card

70 Cancellation of treatment card

Part 8
Revocations

71 Legislative instruments revoked

Schedule 1
Australian statements of principles that apply for purposes of Act

Schedule 2
Rate of disablement pension


Regulations

1 Title
  • These regulations are the Veterans' Support Regulations 2014.

2 Commencement
  • These regulations come into force on 7 December 2014.

3 Interpretation
  • In these regulations, unless the context otherwise requires,—

    • (b) terms used but not defined in these regulations and used or defined in the Act have the same meaning as in the Act:

    • (c) the amount of any rate or other payment is the amount before the deduction of tax (if any).

Part 1
Regulations relating to Part 1 of Act

Treatment providers

4 Additional occupational groups to be treatment providers
  • Regulations 5 to 8 provide that members of certain occupational groups who meet specified criteria are treatment providers for the purposes of the definition of treatment provider in section 7 of the Act.

5 Acupuncturists
  • A person who is an acupuncturist is a treatment provider if the person is—

    • (a) a member of the New Zealand Register of Acupuncturists Incorporated; or

    • (b) a member of the New Zealand Acupuncture Standards Authority Incorporated who—

      • (i) is a qualified health professional registered to practise in some other medical discipline in New Zealand who holds a recognised postgraduate qualification in acupuncture of a minimum of 120 credits (1 year full-time) at Level 8 or above on the New Zealand Register of Quality Assured Qualifications; or

      • (ii) holds a National Diploma in Acupuncture (Level 7) or equivalent according to the criteria for the New Zealand Register of Quality Assured Qualifications.

6 Audiologists
  • A person who is an audiologist is a treatment provider if the person—

    • (a) is a member of the New Zealand Audiological Society Incorporated; and

    • (b) when acting as an audiologist, is not acting—

      • (i) in the course of his or her employment by a supplier of hearing aids; or

      • (ii) as a supplier of hearing aids.

7 Counsellors
8 Speech therapists
  • A person who is a speech therapist is a treatment provider if the person is a member of the New Zealand Speech-Language Therapists’ Association Incorporated.

Paired organs

9 Paired organs
  • The following organs are paired organs for the purposes of section 20 of the Act:

    • (a) adrenal glands:

    • (b) breasts:

    • (c) ears:

    • (d) eyes:

    • (e) kidneys:

    • (f) lungs:

    • (g) ovaries:

    • (h) testicles.

Illnesses and conditions conclusively presumed to be service-related

10 Conclusively presumed illnesses and conditions
  • Regulations 11 to 14 provide that certain illnesses and conditions in relation to certain events or deployments are to be treated as service-related for the purpose of section 21 of the Act.

11 World War II prisoners of war
  • (1) This regulation applies to a veteran if the veteran was a prisoner of war at any time during World War II.

    (2) If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.

    (3) The illnesses and conditions are—

    • (a) any of the anxiety states:

    • (b) beriberi:

    • (c) chronic dysentery:

    • (d) cirrhosis of the liver:

    • (e) dysthymia:

    • (f) heart disease or hypertensive vascular disease, including complications:

    • (g) helminthiasis (intestinal vermiform parasites):

    • (h) hypovitaminosis:

    • (i) irritable bowel syndrome:

    • (j) malnutrition (including optic atrophy):

    • (k) organic residuals of frostbite:

    • (l) peptic ulcer disease:

    • (m) pellagra and any other nutritional deficiencies:

    • (n) peripheral neuropathy:

    • (o) post-traumatic osteoarthritis:

    • (p) psychosis:

    • (q) stroke and residuals of stroke.

12 Exposure to nuclear radiation
  • (1) This regulation applies to a veteran if the veteran served—

    • (a) with J Force in Japan at any time during the years 1946 to 1952; or

    • (b) on HMNZS Pukaki or HMNZS Rotoiti at any time during the years 1957 and 1958; or

    • (c) on HMNZS Otago on 22 July 1973; or

    • (d) on HMNZS Canterbury on 28 July 1973.

    (2) If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.

    (3) The illnesses and conditions are—

    • (a) all forms of leukaemia (except for chronic lymphocytic leukaemia):

    • (b) bronchioloalveolar carcinoma:

    • (c) cancer of the thyroid, breast, pharynx, oesophagus, stomach, small intestine, pancreas, bile ducts, gall bladder, salivary gland, urinary tract (renal, ureter, urinary bladder, or urethra), brain, bone, lung, colon, or ovary:

    • (d) lymphomas (other than Hodgkin’s disease):

    • (e) multiple myeloma:

    • (f) primary liver cancer (except if cirrhosis or hepatitis B is indicated).

13 Vietnam
  • (1) This regulation applies to a veteran if the veteran served in Vietnam—

    • (a) at any time during the period beginning on 29 May 1964 and ending on the close of 31 December 1972; or

    • (b) with 41 Squadron RNZAF at any time during the period beginning on 1 January 1973 and ending on the close of 21 April 1975; or

    • (c) as a member of the civilian surgical team at Qui Nhon Provincial State Hospital, Binh Dinh province at any time during the period beginning on 1 December 1963 and ending on the close of 31 March 1975.

    (2) If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.

    (3) The illnesses and conditions are—

    • (a) acute and subacute peripheral neuropathy:

    • (b) AL-type primary amyloidosis:

    • (c) chloracne:

    • (d) chronic lymphocytic leukaemia (including hairy-cell leukaemia and any other chronic B-cell leukaemias):

    • (e) Hodgkin’s disease:

    • (f) hypertension:

    • (g) ischaemic heart disease:

    • (h) multiple myeloma:

    • (i) non-Hodgkin’s lymphoma:

    • (j) Parkinson’s disease:

    • (k) porphyria cutanea tarda:

    • (l) prostate cancer:

    • (m) respiratory cancers (lung, bronchus, larynx, and trachea):

    • (n) soft tissue sarcoma:

    • (o) stroke:

    • (p) type 2 diabetes.

14 Gulf War
  • (1) This regulation applies to a veteran if the veteran served in the Gulf War at any time during the period beginning on 20 December 1990 and ending on the close of 13 April 1991.

    (2) If the veteran suffers from an illness or a condition in subclause (3), the illness or condition must be treated as service-related.

    (3) The illnesses and conditions are—

    • (a) medically unexplained chronic multi-symptom illnesses—

      • (i) that are defined by a cluster of signs or symptoms, such as—

        • (A) chronic fatigue syndrome:

        • (B) fibromyalgia:

        • (C) irritable bowel syndrome; and

      • (ii) that have existed for 6 months or more:

    • (b) signs or symptoms of an undiagnosed illness that include fatigue, skin symptoms, headaches, muscle pain, joint pain, neurological symptoms, respiratory symptoms, sleep disturbance, gastro-intestinal symptoms, cardiovascular symptoms, weight loss, or menstrual disorders.

Statements of principles

15 Certain Australian statements of principles apply
  • (1) The statements of principles described in Schedule 1 apply for the purposes of the Act.

    (2) The version of a statement of principles referred to in Schedule 1 in the column headed Reasonable hypothesis is to be applied if a veteran’s service-related injury, illness, condition, whole-person impairment, or death relates to qualifying operational service.

    (3) The version of a statement of principles referred to in Schedule 1 in the column headed Balance of probabilities is to be applied if a veteran’s service-related injury, illness, condition, whole-person impairment, or death relates to qualifying routine service.

Indexation of entitlements

16 Formula for indexation of certain entitlements under section 31 of Act
  • (1) This regulation sets out the formula for the indexation of certain entitlements under section 31 of the Act.

    (2) The formula is as follows:

    a  × b
      c

    where—

    a
    is the amount of the entitlement at the date of indexation, before the amount is adjusted
    b
    is the CPI figure for the December quarter immediately prior to the date of indexation
    c
    is the CPI figure for the December quarter prior to the quarter referred to in item b.

    (3) In subclause (2), CPI

    • (a) means the Consumers Price Index (All Groups) published by Statistics New Zealand; but

    • (b) except in relation to adjustments to retirement lump sums payable under section 149 of the Act, does not include index numbers of the CPI for cigarettes and other tobacco products.

    (4) For the purposes of applying the formula in subclause (2),—

    • (a) the number resulting from dividing item b by item c must be rounded up or down to 4 decimal places (with 0.00005 or greater being rounded up):

    • (b) the result must be rounded to the nearest cent as follows:

      • (i) an amount of less than 0.5 cents must be rounded down:

      • (ii) an amount of 0.5 cents or more than 0.5 cents must be rounded up.

    (5) An entitlement that is adjusted by applying the formula takes effect on and from 1 April after the December quarter referred to in item b in subclause (2).

    (6) However, no entitlement is to be adjusted if the application of the formula produces a negative figure.

Part 2
Regulations relating to Part 3 of Act

Rate of disablement pension

17 Rate of disablement pension
  • (1) The rate of a veteran’s disablement pension payable under section 56 of the Act is to be determined according to the level of the veteran’s whole-person impairment.

    (2) The rates of the disablement pension are set out in Schedule 2.

    (3) A veteran’s level of whole-person impairment in the first column of Schedule 2 is to be determined in accordance with the American Medical Association Guides to the Evaluation of Permanent Impairment (4th ed).

    (4) To avoid doubt, the level of whole-person impairment of a veteran who is applying for a disablement pension under clause 6(2) of Schedule 1 of the Act is to be assessed in accordance with the American Medical Association Guides to the Evaluation of Permanent Impairment (4th ed).

Surviving spouse or partner pension

18 Rate of surviving spouse or partner pension
  • The rate of the surviving spouse or partner pension payable under section 66 of the Act is $160.04 per week.

Children’s pension

19 Rate of children’s pension
  • The rate of the children’s pension payable under section 72 of the Act is $171.38 per week.

Dependant’s pension

20 Maximum rate of dependant’s pension
  • The maximum rate of a dependant’s pension payable under section 76 of the Act is $160.04 per week.

21 VANZ to take into account dependant’s economic position in determining actual rate
  • (1) Regulations 22 to 25 specify the criteria that VANZ must take into account in assessing a dependant’s economic position for the purpose of determining the rate of a dependant’s pension payable to the dependant.

    (2) If, at any time, VANZ has reason to believe that a dependant’s economic position has changed, VANZ may reassess the dependant’s economic position in order to determine the appropriate rate payable to the dependant.

22 Rate of dependant’s pension
  • (1) If a dependant’s weekly income is equal to or less than 50% of the maximum rate, the pension payable to the dependant is the maximum rate.

    (2) If a dependant’s weekly income is more than 50% of the maximum rate, the pension payable to the dependant is the maximum rate minus $1 for every $1 of income that exceeds 50% of the maximum rate.

    (3) For the purposes of this regulation, a dependant’s weekly income is the amount equivalent to the dependant’s income (inclusive of any income tax) during the preceding 12-month period divided by 52.

23 Dependant’s income
  • (1) For the purposes of regulation 22(3), a dependant’s income includes—

    • (a) income received by the dependant:

    • (b) income received by the dependant’s spouse or partner:

    • (d) income derived from assets owned by the dependant:

    • (e) income derived from assets owned by the dependant’s spouse or partner.

    (2) A dependant’s income does not include—

    • (a) any assets received by the dependent, or the dependant’s spouse or partner, that are defined as exempt assets, exempted from a means assessment, or declared not to be cash assets under a social security enactment:

    • (b) any income derived from assets of the type described in paragraph (a):

    • (c) any income that is exempted from a means assessment or declared not to be income under a social security enactment:

    • (d) the dependant’s interest in a residential dwelling that is the dependant’s principal residence:

    • (e) the dependant’s interest in a car or similar vehicle for the dependant’s own use.

    (3) In this regulation, unless the context otherwise requires,—

    income has the meaning given by section 3(1) of the Social Security Act 1964

    social security enactment means—

    (4) For the purposes of this regulation, any reference in an enactment referred to in subclause (3) to the chief executive is to be read as a reference to VANZ.

24 Deprivation of assets and income
  • (1) If VANZ is satisfied that a dependant, or the dependant’s spouse or partner, has directly or indirectly deprived himself or herself of any assets or income, VANZ, in assessing the dependant’s economic position, may treat the deprivation as if it had not occurred.

    (2) Subclause (1) does not apply if the deprivation occurred before the veteran for which the pension is payable—

    • (a) died; or

    • (b) became entitled to—

      • (i) a war disablement pension under Part 2 of the War Pensions Act 1954 in relation to disablement of 70% or more; or

      • (ii) a disablement pension under subpart 3 of Part 3 of the Act in relation to whole-person impairment of 52% or more.

25 How value of land to be determined
  • (1) If an assessment of a dependant’s economic position involves determining the value of land, the value is to be determined in accordance with regulations 9D and 9E of the Social Security (Long-term Residential Care) Regulations 2005.

    (2) For the purposes of subclause (1), regulations 9D and 9E of those regulations apply with all necessary modifications and as if references to the chief executive were references to VANZ.

Children’s bursaries

26 Rates of children’s bursaries
  • (1) This regulation specifies the rates of children’s bursaries payable under section 81 of the Act.

    (2) The children’s bursary payable in respect of a child who, immediately before the commencement of Part 3 of the Act, was receiving a children’s pension under section 40 of the War Pensions Act 1954 or who is the child of a veteran receiving a veteran’s pension is—

    • (a) $905.75, if the child is undertaking full-time study at a secondary school:

    • (b) $452.82, if the child is undertaking part-time study at a tertiary institution:

    • (c) $1,074.78, if the child is undertaking full-time study at a tertiary institution.

    (3) The children’s bursary payable to a child who is not described in subclause (2) is—

    • (a) $452.84, if the child is undertaking full-time study at a secondary school:

    • (b) $226.41, if the child is undertaking part-time study at a tertiary institution:

    • (c) $537.36, if the child is undertaking full-time study at a tertiary institution.

    (4) A children’s bursary is paid annually in the year in which a child is entitled to the bursary.

Part 3
Regulations relating to Part 5 of Act

Weekly battery allowance

27 Entitlement to weekly battery allowance
  • A veteran is entitled to a weekly battery allowance if the veteran—

    • (a) has a service-related hearing loss; and

    • (b) is using a hearing aid that is approved by VANZ and that VANZ considers necessary and suitable for the veteran’s service-related hearing loss; and

    • (c) is not being—

      • (i) supplied with hearing aid batteries from anyone other than VANZ; or

      • (ii) provided with funding for hearing aid batteries from anyone other than VANZ.

28 Rate of weekly battery allowance
  • The rate of the weekly battery allowance for the purposes of section 145(b) of the Act is—

    • (a) $1.05, if a hearing aid is required for only 1 ear:

    • (b) $2.13, if a hearing aid is required for each ear.

Motor vehicle grants

29 Interpretation
  • (1) In regulations 30 and 31,—

    severe lower body mobility impairment means a service-related impairment due to—

    • (a) amputation of a lower limb; or

    • (b) severe and permanent loss of function of the lower extremity affecting mobility

    total lower body mobility impairment means a service-related impairment due to—

    • (a) paraplegia; or

    • (b) amputation of both lower limbs; or

    • (c) total or near-total permanent loss of function of the lower extremity affecting mobility.

    (2) For the purposes of subclause (1), lower extremity means that part of the body from both hips (including the pelvis) to the toes of both feet.

30 Maximum amount of grant
  • The maximum amount of a motor vehicle grant under section 147 of the Act is—

    • (a) $8,361.87, in the case of severe lower body mobility impairment:

    • (b) $18,580.73, in the case of total lower body mobility impairment.

31 Frequency of grants
  • (1) A motor vehicle grant in relation to severe lower body mobility impairment may be made to a veteran only once.

    (2) A motor vehicle grant in relation to total lower body mobility impairment may be made more than once, but only at intervals of not less that 5 years.

32 Additional grant for fitting controls
  • A veteran who receives a motor vehicle grant may also apply for an additional grant, up to a maximum of $3,000, for the purpose of fitting special driving controls to a vehicle without which the veteran would be unable to drive the vehicle.

33 Criteria for determining whether to make grant
  • The matters to be taken into account in determining whether to make a grant or an additional grant in relation to a motor vehicle are—

    • (a) the nature and extent of a veteran’s lower body impairment; and

    • (b) the veteran’s need for a motor vehicle or for the special controls; and

    • (c) the suitability of the motor vehicle or the special controls for the veteran’s impairment and needs; and

    • (d) the cost and condition of the motor vehicle or the special controls; and

    • (e) whether the veteran will be able to drive the vehicle safely; and

    • (f) whether the veteran will be legally permitted to drive the motor vehicle in the country in which the veteran intends to operate the vehicle (including whether the veteran holds or will be able to hold a valid driver’s licence); and

    • (g) whether the motor vehicle or the special controls will comply with or be exempted from any applicable laws for operation of a motor vehicle in the country in which the veteran intends to operate that vehicle, such as vehicle registration and warrant of fitness; and

    • (h) whether the veteran has or is able to obtain comprehensive motor vehicle insurance for the motor vehicle; and

    • (i) if the motor vehicle is a mobility scooter or similar vehicle, whether the veteran has a medical certificate that indicates the veteran is capable of operating the vehicle; and

    • (j) whether the veteran has received any previous assistance from VANZ, including (but not limited to) a motor vehicle loan under the War Pensions Act 1954, and how long ago that assistance was received; and

    • (k) whether the veteran has received any money from the sale of a motor vehicle, or any part of a motor vehicle, that VANZ has previously helped purchase (and, if so, the amount received).

Retirement lump sums

34 Amount of retirement lump sum
  • The retirement lump sum under section 149 of the Act is $33,000.

35 Asset threshold for non-exempt assets
  • (1) This regulation specifies the asset threshold for non-exempt assets for the purposes of section 149 of the Act, being the threshold at or above which a veteran does not qualify for a retirement lump sum under that section.

    (2) The asset threshold for a veteran who does not have a spouse or partner is $500,000, including the value of a residential dwelling and a vehicle.

    (3) A veteran who has a spouse or partner may elect one of the following asset thresholds:

    • (a) $300,000, excluding the value of a residential dwelling and a vehicle:

    • (b) $500,000, including the value of a residential dwelling and a vehicle.

36 Assets to be included in asset assessment
  • (1) Assets to be included in an asset assessment under section 150 of the Act are the assets of the veteran and his or her spouse or partner (if any) that would come within the definition of assets in clause 4 of Schedule 27 of the Social Security Act 1964 (if the veteran were a person being means assessed under section 146 of that Act).

    (2) However, assets that are exempt assets and gifts that are allowable gifts are not included in an asset assessment.

    (3) For the purposes of subclause (2),—

    • (a) an asset is an exempt asset if it would be an exempt asset under—

      • (i) clause 4 of Schedule 27 of the Social Security Act 1964; or

      • (ii) regulation 10 of the Social Security (Long-term Residential Care) Regulations 2005:

    • (b) a gift is an allowable gift if the gift would be or would be treated as an allowable gift under regulations 9 and 9A of the Social Security (Long-term Residential Care) Regulations 2005.

37 Deprivation of assets
  • (1) If VANZ is satisfied that a veteran or his or her spouse or partner (if any) has directly or indirectly deprived himself or herself of any assets (other than exempt assets), the veteran’s asset assessment under section 150 of the Act may be conducted as if the deprivation had not occurred.

    (2) For the purposes of subclause (1), instances of deprivation of assets include, but are not limited to, the instances described in regulation 9B(a) to (f) of the Social Security (Long-term Residential Care) Regulations 2005.

38 Gifting period
  • For the purposes of clauses 36 and 37, a reference to the gifting period in clause 4 of Schedule 27 of the Social Security Act 1964 and in regulations 9 to 9B of the Social Security (Long-term Residential Care) Regulations 2005 is to be read as the period of 5 years immediately preceding the date on which the veteran reached the New Zealand superannuation qualification age.

39 How value of land to be determined
  • (1) If an asset assessment under section 150 of the Act involves determining the value of land, the value is to be determined in accordance with regulations 9D and 9E of the Social Security (Long-term Residential Care) Regulations 2005.

    (2) For the purposes of subclause (1), regulations 9D and 9E of those regulations apply with all necessary modifications and as if references to the chief executive were references to VANZ.

Funeral expenses

40 Funeral expenses
  • For the purposes of sections 153 and 154 of the Act, the maximum amount payable in relation to expenses of a funeral and burial or cremation of a veteran is $2,442.96.

41 Cost of transport of veteran’s body
  • For the purposes of section 153(5) of the Act, the maximum amount payable for transporting a veteran’s body from the hospital in which he or she died to the place of the veteran’s burial or cremation is—

    • (a) $650, if the place is within the locality of the hospital:

    • (b) $1,300, if the place is outside the locality of the hospital.

Part 4
Regulations relating to Part 6 of Act

Rates of veteran’s pension

42 Rates of veteran’s pension
  • (1) This regulation specifies the rates of veteran’s pension payable under Part 6 of the Act (subject to any abatement under section 171 of the Act).

    (2) The single living alone rate is $421.76 per week.

    (3) The single sharing accommodation rate is $387.58 per week.

    (4) The relationship rate is $319.23 per week.

    (5) The relationship (partner not receiving superannuation or pension) rate is $604.54 per week.

    (6) The relationship (partner not receiving superannuation or pension) legacy rate is $638.46 per week.

Lump sum payment on death

43 Lump sum payment on death of veteran
  • (1) This regulation specifies the amount payable under section 174(2) of the Act on the death of—

    • (a) a veteran to whom section 162(1) of the Act applies and who, on the date of death,—

      • (i) is ordinarily resident in New Zealand; and

      • (ii) is receiving a veteran’s pension; or

    • (b) a veteran who, on the date of death,—

      • (i) is ordinarily resident in New Zealand; and

      • (ii) is receiving a veteran’s pension under section 164 of the Act.

    (2) The amount is $5,791.47.

    (3) However, if the veteran was, before 1 April 1990, receiving a war veteran’s allowance under the War Pensions Act 1954, the amount is $14,602.73.

44 Lump sum payment on death of spouse or partner of veteran
  • (1) This regulation specifies the amount payable under section 174(4) of the Act on the death of the spouse or partner of a veteran if, on the date of death, the spouse or partner—

    • (a) is ordinarily resident in New Zealand; and

    • (b) is receiving a veteran’s pension under section 162(2) of the Act.

    (2) The amount is $4,416.16.

Part 5
Regulations relating to Part 7 of Act

45 Procedure for appeals against review decisions
46 Interpretation
  • In this Part, unless the context otherwise requires,—

    evidence means any evidence or information, whether or not that evidence or information would be admissible in a court of law

    party

    • (a) means a party to an appeal; and

    • (b) includes VANZ.

47 VANZ must advise applicant of right to appeal
  • VANZ must, when notifying the outcome of a review decision to the person who applied for the review, advise the person—

    • (a) of the right to appeal the review decision; and

    • (b) of the time limit for bringing an appeal; and

    • (c) that the person can obtain the form of the notice of appeal directly from VANZ or from VANZ’s Internet site.

48 Notice of appeal
  • (1) The notice of appeal must be made in writing and in the form provided by VANZ for the purpose.

    (2) The notice of appeal must specify—

    • (a) the review decision under appeal; and

    • (b) the grounds for the appeal.

    (3) The notice of appeal must contain the following information:

    • (a) the full name of the veteran or other claimant; and

    • (b) a postal, physical, or electronic address to which information and notices concerning the appeal can be delivered to the appellant; and

    • (c) whether the veteran or other claimant proposes to attend the hearing; and

    • (d) any other information required by the form provided by VANZ for the purpose.

    (4) The form provided by VANZ may require the appellant to specify any evidence on which the appellant intends to rely for the appeal.

49 Notice of hearing
  • (1) The appeal board must set a date and location for the hearing of an appeal.

    (2) Not later than 20 working days before the hearing date, the appeal board must notify the parties of the hearing date and location of the hearing.

50 Case management conferences and directions
  • (1) The appeal board may hold a case management conference at any time.

    (2) If the appeal board considers that it will secure the just, speedy, and inexpensive determination of an appeal, or it is otherwise in the interests of justice, the appeal board may give a direction in relation to the management of the case.

    (3) A direction under subclause (2) may be given on the appeal board's own initiative, or on the application of a party.

51 Evidence
  • (1) Each party must, not later than 10 working days before the hearing date, provide all evidence on which that party wishes to rely at the hearing to the other party.

    (2) However, a party may provide further evidence at a later date in accordance with a direction given by the appeal board under regulation 50(2).

    (3) After determining an appeal, the appeal board must return all evidence provided to it by the veteran or other claimant, if the veteran or other claimant so requires.

    (4) To avoid doubt, VANZ may keep copies of any evidence provided to it.

52 Appellant not giving oral evidence
  • (1) This regulation applies if the appellant does not provide oral evidence (whether by attending the hearing or remotely by electronic means).

    (2) If the appeal board decides that it cannot determine the appeal without hearing oral evidence from the appellant, the appeal is to be treated as having lapsed, but the appeal board may (on the application of the appellant) revive the appeal.

    (3) If the appeal board decides that it can determine the appeal without hearing oral evidence from the appellant, the appeal board may proceed to determine the appeal.

    (4) The appeal board must not make a decision under subclause (2) or (3) unless it has given the appellant—

    • (a) prior notice that it is considering making the decision; and

    • (b) a reasonable opportunity to respond.

53 Appeal may continue on death of veteran or other claimant
  • If a veteran or other claimant dies before his or her appeal has been determined, the appeal may be continued by his or her personal representative or by any other suitable person.

Part 6
Regulations relating to Part 8 of Act

Procedure of Veterans’ Advisory Board and Veterans’ Health Advisory Panel

54 Interpretation
  • (1) In this Part, unless the context otherwise requires,—

    advisory body means the Veterans’ Advisory Board or the Veterans’ Health Advisory Panel

    chairperson

    • (a) means the chairperson of an advisory body; and

    • (b) includes the acting chairperson of an advisory body, if one has been appointed under section 248(4) or 255(5) of the Act (as applicable)

    deputy chairperson means the deputy chairperson of an advisory body

    matter means an advisory body’s performance of its functions or exercise of its powers

    member

    • (a) means a member of an advisory body; and

    • (b) includes the chairperson and the deputy chairperson of the advisory body.

    (2) In this Part, a member is interested in a matter if he or she—

    • (a) may derive a financial benefit from the matter; or

    • (b) is the spouse, civil union partner, de facto partner, child, or parent of a person who may derive a financial benefit from the matter; or

    • (c) may have a financial interest in a person to whom the matter relates; or

    • (d) is a partner, director, officer, board member, or trustee of a person who may have a financial interest in a person to whom the matter relates; or

    • (e) is otherwise directly or indirectly interested in the matter.

    (3) However, a member is not interested in a matter—

    • (a) only because he or she receives an entitlement under the Act; or

    • (b) if his or her interest is so remote or insignificant that it cannot reasonably be regarded as likely to influence him or her in carrying out his or her responsibilities under the Act; or

    • (c) only because he or she has past or current involvement in the defence sector, in medical research, or in veterans’ matters.

Meetings

55 Notice of meetings
  • (1) An advisory body or the chairperson (or, if there is no chairperson or the chairperson is unavailable, the deputy chairperson) must appoint the times and places of ordinary meetings of the advisory body, and VANZ must give written notice of those meetings to each member.

    (2) Notice of a meeting—

    • (a) must state the time and place of the meeting; and

    • (b) must be sent to each member's current postal or electronic address.

    (3) An irregularity in the notice of a meeting is waived if all members entitled to receive the notice—

    • (a) attend the meeting without protesting about the irregularity; or

    • (b) do not attend the meeting, but agree before the meeting is held to waive the irregularity.

    Compare: 2004 No 115 Schedule 5 cl 7

56 Methods of holding meetings
  • A meeting of an advisory body may be held—

    • (a) by a quorum of members being assembled together at the time and place appointed for the meeting; or

    • (b) by means of audio, audiovisual, or electronic communication if—

      • (i) all of the members who wish to participate in the meeting have access to the technology needed to participate in the meeting; and

      • (ii) a quorum of members can simultaneously communicate with each other throughout the meeting.

    Compare: 2004 No 115 Schedule 5 cl 8

57 Unanimous written resolutions
  • A resolution signed or assented to in writing (whether by post, delivery, or electronic communication) by all members who are entitled to vote on the matter is as valid and effectual as if it had been passed unanimously at a meeting of the advisory body duly called and constituted.

    Compare: 2004 No 115 Schedule 5 cl 13

Disclosure of interests

58 Obligation to disclose interest
  • (1) A member who is interested in a matter relating to an advisory body must disclose details of the interest in accordance with regulation 59 as soon as practicable after the member becomes aware that he or she is interested.

    (2) A general notice of an interest in a matter relating to an advisory body, or in a matter that may in future relate to an advisory body, that is disclosed in accordance with regulation 59 is a standing disclosure of that interest for the purposes of this regulation.

    (3) A standing disclosure ceases to have effect if the nature of the interest materially alters or the extent of the interest materially increases.

    Compare: 2004 No 115 s 63

59 Who disclosure of interests must be made to
  • The member must disclose details of the interest in an interests register kept by VANZ and to—

    • (a) the chairperson or, if there is no chairperson or if the chairperson is unavailable or interested, the deputy chairperson; or

    • (b) the Minister, if there is neither a chairperson nor a deputy chairperson, or if both the chairperson and the deputy chairperson are unavailable or interested.

    Compare: 2004 No 115 s 64

60 What must be disclosed
  • The details that must be disclosed under regulation 59 are—

    • (a) the nature of the interest and the monetary value of the interest (if the monetary value can be quantified); or

    • (b) the nature and extent of the interest (if the monetary value cannot be quantified).

    Compare: 2004 No 115 s 65

61 Consequences of being interested in matter
  • (1) A member who is interested in a matter relating to an advisory body—

    • (a) must not vote or take part in any discussion of the advisory body in relation to the matter, or otherwise participate in any activity of the advisory body in relation to the matter; and

    • (b) must not take part in any decision of the advisory body in relation to the matter or sign or otherwise endorse any document containing the advisory body’s advice, comments, or decisions relating to the matter; and

    • (c) is to be disregarded for the purpose of forming a quorum for that part of a meeting of the advisory body during which a discussion or decision relating to the matter occurs or is made.

    (2) This regulation is subject to regulation 63.

    Compare: 2004 No 115 s 66

62 Consequences of failing to disclose interest
  • The advisory body must notify the Minister of a failure to comply with regulation 58 or 61, and of the affected matters or acts, as soon as practicable after becoming aware of the failure.

    Compare: 2004 No 115 s 67

63 Permission to act despite being interested in matter
  • (1) The chairperson may, by prior written notice to the advisory body or by a ruling during a meeting, permit 1 or more members, or members with a specified class of interest, to take part in any discussion (but not in any decision) of the advisory body in relation to the matter to which the interest relates if the chairperson is satisfied that it is in the public interest to do so.

    (2) The permission may state conditions that the member or members must comply with.

    (3) The deputy chairperson may give the permission if there is no chairperson or if the chairperson is unavailable or interested.

    (4) The Minister may give the permission if there is neither a chairperson nor a deputy chairperson, or if both the chairperson and the deputy chairperson are unavailable or interested.

    (5) A permission may be amended or revoked in the same way as it was given.

    (6) The advisory body must disclose an interest to which a permission relates in every document to which the interest relates, together with a statement of who gave the permission and any conditions of, amendments to, or revocation of the permission.

    Compare: 2004 No 115 s 68

Part 7
Regulations relating to Part 9 of Act

Treatment cards

64 Issue of treatment card
  • VANZ may issue a treatment card to a veteran if the veteran has an injury, illness, or condition—

    • (a) that is service-related; and

    • (b) for which VANZ will pay or contribute towards the cost of treatment.

65 Information to be included on treatment card
  • A treatment card issued to a veteran must include the following information:

    • (a) the veteran’s—

      • (i) full name; and

      • (ii) VANZ reference number; and

      • (iii) Defence Force number (if applicable); and

      • (iv) national health index number:

    • (b) the card’s date of issue:

    • (c) the card’s date of expiry (if issued for a limited period):

    • (d) a description of the injuries, illnesses, or conditions that the veteran has and for which VANZ will pay or contribute towards the cost of treatment:

    • (e) how to contact VANZ:

    • (f) a statement to the effect that—

      • (i) VANZ will pay or contribute towards (whichever is applicable) the cost of treatment of the service-related injuries, illnesses, or conditions described on the card; but

      • (ii) VANZ will not pay or contribute towards the cost of specialist treatment unless VANZ has given its prior approval.

66 Obligations of treatment card holders
  • A veteran to whom a treatment card is issued must—

    • (a) use the card only as evidence of the service-related injuries, illnesses, or conditions described on the card that the veteran has and for which VANZ will pay or contribute towards the cost of treatment; and

    • (c) comply with all other requirements and restrictions relating to the use of treatment cards specified in regulations 68 and 69.

67 Conditions of use
  • (1) If a veteran’s treatment card is lost, stolen, or destroyed, the veteran must (as soon as possible after becoming aware that this has happened) tell VANZ that his or her treatment card has been lost, stolen, or destroyed.

    (2) A veteran must return his or her treatment card to VANZ as soon as possible if—

    • (a) the treatment card is damaged; or

    • (b) VANZ has requested (in writing) the veteran to return the card to VANZ.

    (3) A veteran must not add to, amend, or remove any information recorded on a treatment card.

    (4) A veteran must comply with any other requirement that—

    • (a) is notified in writing by VANZ to the veteran; and

    • (b) is reasonably necessary for the use of the treatment card or treatment cards generally.

68 Unauthorised uses of treatment card
  • (1) A treatment card must not—

    • (a) be used for any dishonest or improper purpose; or

    • (b) be used after a veteran has received a notice in writing from VANZ recalling or cancelling the treatment card; or

    • (c) be given, lent, or sold to another person.

    (2) However, subclause (1)(c) does not apply if a treatment card is given to another person to obtain, on behalf of a veteran, a service to which the veteran is entitled.

69 Recall of treatment card
  • VANZ may require a veteran to return a treatment card if—

    • (a) the information on the card needs to be changed; or

    • (b) the veteran is no longer entitled to the card; or

    • (c) VANZ considers, on reasonable grounds, that the veteran—

      • (i) has not complied with the conditions relating to the use of the card; or

      • (ii) has used the card for an unauthorised purpose.

70 Cancellation of treatment card
  • (1) VANZ may cancel a veteran’s treatment card by notice in writing to the veteran if VANZ considers, on reasonable grounds, that—

    • (a) the veteran is not entitled to the treatment card; or

    • (b) the veteran has asked VANZ to cancel the treatment card; or

    • (c) the veteran has, without good reason, refused to return the card after VANZ has requested its return; or

    • (d) the veteran has not complied with the conditions relating to the use of the card; or

    • (e) the veteran has used the card for an unauthorised purpose.

    (2) VANZ may not cancel a treatment card under subclause (1)(a), (c), (d), or (e) unless it has—

    • (a) given the veteran notice in writing—

      • (i) that it proposes to cancel the card; and

      • (ii) of the grounds for the proposed cancellation; and

    • (b) given the veteran a reasonable opportunity to provide VANZ with any reasons why it should not cancel the card; and

    • (c) carefully considered any reasons provided under paragraph (b).

Part 8
Revocations

71 Legislative instruments revoked

Schedule 1
Australian statements of principles that apply for purposes of Act

r 15

  Number
Condition Reasonable hypothesis Balance of probabilities
accidental hypothermia 17/2010 18/2010
accommodation disorder 5/2009 6/2009
Achilles tendinopathy and bursitis 37/2007 38/2007
acoustic neuroma 29/2011 30/2011
acquired cataract 39/2008 40/2008
acute articular cartilage tear 53/2010 54/2010
acute infectious mononucleosis 3/2012 4/2012
acute lymphoblastic leukaemia 75/2012 76/2012
acute meniscal tear of the knee 55/2010 56/2010
acute myeloid leukaemia 35/2006 36/2006
acute pancreatitis 85/2011 86/2011
acute rheumatic fever 23/2011 24/2011
acute stress disorder 41/2014 42/2014
adenocarcinoma of the kidney 9/2013 10/2013
adhesive capsulitis of the shoulder 7/2012 8/2012
adjustment disorder 37/2008 38/2008
adrenal insufficiency 74/2009 75/2009
albinism 45/2007 46/2007
alcohol use disorder 1/2009 2/2009
alkaptonuria 47/2007 48/2007
allergic contact dermatitis 112/2011 113/2011
allergic rhinitis 22/2014 23/2014
alpha-1 antitrypsin deficiency 01/2007 02/2007
Alzheimer-type dementia 22/2010 23/2010
anal fissure 73/2010 74/2010
analgesic nephropathy 29/2008 30/2008
angle-closure glaucoma 25/2012 26/2012
animal envenomation 66/2008 67/2008
ankylosing spondylitis 3/2013 4/2013
anosmia 118/2011 119/2011
anxiety disorder 101/2007 102/2007
aortic aneurysm 9/2012 10/2012
aortic stenosis 21/2013 22/2013
aplastic anaemia 50/2012 51/2012
asbestosis 55/2013 56/2013
ascariasis 62/2008 63/2008
asthma 60/2012 61/2012
atherosclerotic peripheral vascular disease 23/2012 24/2012
atrial fibrillation and atrial flutter 49/2014 50/2014
autosomal dominant polycystic kidney disease 55/2007 56/2007
benign neoplasm of the eye and adnexa 33/2008 34/2008
benign prostatic hyperplasia 19/2008 20/2008
bipolar disorder 27/2009 28/2009
blepharitis 63/2010 64/2010
bronchiectasis 17/2009 18/2009
bronchiolitis obliterans organising pneumonia 62/2009 63/2009
cardiac myxoma 11/2009 12/2009
cardiomyopathy 23/2007 24/2007
carotid arterial disease 37/2012 38/2012
carpal tunnel syndrome 7/2013 8/2013
cerebral meningioma 19/2009 20/2009
cerebrovascular accident 51/2006 52/2006
cervical spondylosis 66/2014 67/2014
Charcot-Marie-Tooth disease 09/2007 10/2007
chicken pox 25/2007 26/2007
chilblains 9/2009 10/2009
chloracne 17/2012 18/2012
cholelithiasis 7/2008 8/2008
chondromalacia patella 79/2010 80/2010
chronic fatigue syndrome 11/2014 12/2014
chronic gastritis and chronic gastropathy 25/2013 26/2013
chronic lymphocytic leukaemia/small lymphocytic lymphoma 84/2014 85/2014
chronic multisymptom illness 55/2014 56/2014
chronic myeloid leukaemia 47/2014 48/2014
chronic obstructive pulmonary disease 37/2014 38/2014
chronic pancreatitis 104/2011 105/2011
chronic pruritus ani 75/2010 76/2010
chronic solvent encephalopathy 71/2013 72/2013
chronic venous insufficiency of the lower limb 29/2012 30/2012
cirrhosis of the liver 107/2007 108/2007
clonorchiasis 113/2007 114/2007
cluster headache 20/2010 21/2010
coeliac disease 1/2011 2/2011
colorectal adenoma 35/2013 36/2013
concussion 64/2012 65/2012
conductive hearing loss 7/2011 8/2011
congenital cataract 49/2007 50/2007
conjunctivitis 1/2012 2/2012
Creutzfeldt-Jakob disease 76/2014 77/2014
Cushing's syndrome 33/2009 34/2009
cut, stab, abrasion and laceration 3/2008 4/2008
decompression sickness 43/2006 44/2006
deep vein thrombosis 54/2012 55/2012
dementia pugilistica 11/2012 12/2012
dengue fever 13/2012 14/2012
dental caries 71/2007 72/2007
dental malocclusion 17/2011 18/2011
dental pulp and apical disease 3/2014 4/2014
depressive disorder 27/2008 28/2008
dermatomyositis 9/2014 10/2014
diabetes mellitus 89/2011 90/2011
dislocation 24/2010 25/2010
diverticular disease of the colon 13/2008 14/2008
Dupuytren's disease 57/2010 58/2010
dysbaric osteonecrosis 47/2006 48/2006
eating disorder 47/2008 48/2008
electrical injury 31/2009 32/2009
endometriosis 41/2012 42/2012
epicondylitis 52/2004 53/2004
epilepsy 75/2013 76/2013
epileptic seizure 77/2013 78/2013
erectile dysfunction 43/2013 44/2013
essential thrombocythaemia 15/2013 16/2013
external bruise 109/2007 110/2007
external burn 41/2006 42/2006
extrinsic allergic alveolitis 87/2011 88/2011
familial adenomatous polyposis 39/2013 40/2013
familial hypertrophic cardiomyopathy 35/2007 36/2007
fibromuscular dysplasia 60/2008 61/2008
fibromyalgia 13/2014 14/2014
fibrosing interstitial lung disease 53/2013 54/2013
fracture 53/2006 54/2006
frostbite 23/2009 24/2009
gastric ulcer and duodenal ulcer 57/2006 58/2006
gastro-oesophageal reflux disease 65/2013 66/2013
Gaucher's disease 03/2007 04/2007
giant cell arteritis 71/2012 72/2012
gingivitis 45/2013 46/2013
goitre 23/2013 24/2013
gout 30/2010 31/2010
Graves' disease 33/2013 34/2013
Guillain-Barre syndrome 59/2013 60/2013
haemochromatosis 21/2012 22/2012
haemophilia 63/2007 64/2007
haemorrhoids 41/2008 42/2008
hallux valgus 91/2007 92/2007
Hashimoto's thyroiditis 31/2013 32/2013
heart block 1/2014 2/2014
heel bursitis 77/2010 78/2010
hepatitis A 29/2007 30/2007
hepatitis B 52/2008 53/2008
hepatitis C 54/2008 55/2008
hepatitis D 56/2008 57/2008
hepatitis E 31/2007 32/2007
hereditary spherocytosis 13/2007 14/2007
herpes simplex 3/2010 4/2010
herpes zoster 27/2007 28/2007
hiatus hernia 68/2014 69/2014
Hodgkin's lymphoma 35/2014 36/2014
hookworm disease 64/2008 65/2008
horseshoe kidney 51/2007 52/2007
human immunodeficiency virus 5/2010 6/2010
human T-cell lymphotropic virus type 1 7/2010 8/2010
Huntington's chorea 05/2007 06/2007
hypertension 63/2013 64/2013
hyperthyroidism and thyrotoxicosis 27/2013 28/2013
hypopituitarism 76/2009 77/2009
hypothyroidism 29/2013 30/2013
iliotibial band syndrome 34/2010 35/2010
immersion foot 25/2009 26/2009
immune thrombocytopaenic purpura 72/2008 73/2008
inflammatory bowel disease 19/2012 20/2012
influenza 58/2009 59/2009
ingrowing nail 93/2007 94/2007
inguinal hernia 5/2013 6/2013
internal derangement of the knee 51/2010 52/2010
intervertebral disc prolapse 39/2007 40/2007
irritable bowel syndrome 27/2011 28/2011
irritant contact dermatitis 110/2011 111/2011
ischaemic heart disease 89/2007 90/2007
joint instability 32/2010 33/2010
Kaposi's sarcoma 9/2011 10/2011
labral tear 94/2010 95/2010
leptospirosis 50/2004 51/2004
lipoma 97/2007 98/2007
localised sclerosis 66/2009 67/2009
loss of teeth 73/2007 74/2007
lumbar spondylosis 62/2014 63/2014
macular degeneration 13/2009 14/2009
malaria 60/2009 61/2009
malignant melanoma of the skin 79/2007 80/2007
malignant neoplasm of bone and articular cartilage 106/2011 107/2011
malignant neoplasm of the anus and anal canal 51/2013 52/2013
malignant neoplasm of the bile duct 21/2007 22/2007
malignant neoplasm of the bladder 96/2011 97/2011
malignant neoplasm of the brain 58/2008 59/2008
malignant neoplasm of the breast 27/2006 28/2006
malignant neoplasm of the cerebral meninges 21/2009 22/2009
malignant neoplasm of the cervix 39/2012 40/2012
malignant neoplasm of the colorectum 37/2013 38/2013
malignant neoplasm of the endometrium 99/2007 100/2007
malignant neoplasm of the eye 15/2010 16/2010
malignant neoplasm of the gallbladder 67/2007 68/2007
malignant neoplasm of the larynx 61/2013 62/2013
malignant neoplasm of the liver 21/2011 22/2011
malignant neoplasm of the lung 17/2006 18/2006
malignant neoplasm of the nasopharynx 25/2011 26/2011
malignant neoplasm of the oesophagus 41/2007 42/2007
malignant neoplasm of the oral cavity, oropharynx and hypopharynx 1/2013 2/2013
malignant neoplasm of the ovary 70/2009 71/2009
malignant neoplasm of the pancreas 73/2013 74/2013
malignant neoplasm of the prostate 53/2014 54/2014
malignant neoplasm of the renal pelvis and ureter 98/2011 99/2011
malignant neoplasm of the salivary gland 46/2004 47/2004
malignant neoplasm of the small intestine 40/2004 41/2004
malignant neoplasm of the stomach 58/2014 59/2014
malignant neoplasm of the testis and paratesticular tissues 15/2004 16/2004
malignant neoplasm of the thyroid gland 39/2014 40/2014
malignant neoplasm of the urethra 1/2008 2/2008
malignant neoplasm of unknown primary site 80/2014 81/2014
Marfan syndrome 53/2007 54/2007
melioidosis 60/2014 61/2014
Meniere's disease 59/2006 60/2006
mesangial IgA glomerulonephritis 52/2012 53/2012
mesothelioma 83/2007 84/2007
methaemoglobinaemia 47/2010 48/2010
microscopic polyangiitis 13/2011 14/2011
migraine 56/2009 57/2009
mitral valve prolapse 43/2014 44/2014
moderate to severe traumatic brain injury 62/2012 63/2012
morbid obesity 5/2014 6/2014
Morton's metatarsalgia 92/2010 93/2010
motor neurone disease 67/2013 68/2013
multiple osteochondromatosis 11/2007 12/2007
multiple sclerosis 100/2011 101/2011
myasthenia gravis 15/2007 16/2007
myelodysplastic disorder 37/2006 38/2006
myeloma 69/2012 70/2012
myopia, hypermetropia and astigmatism 69/2007 70/2007
narcolepsy 7/2014 8/2014
neoplasm of the pituitary gland 42/2004 43/2004
non-aneurysmal aortic atherosclerotic disease 15/2012 16/2012
non-Hodgkin's lymphoma 28/2010 29/2010
non-melanotic malignant neoplasm of the skin 81/2007 82/2007
obstructive and reflux neophropathy 31/2011 32/2011
open-angle glaucoma 27/2012 28/2012
opisthorchiasis 111/2007 112/2007
osteoarthritis 13/2010 14/2010
osteogenesis imperfecta 59/2007 60/2007
osteomyelitis 05/2004 06/2004
osteoporosis 29/2006 30/2006
otitic barotrauma 35/2012 36/2012
otitis externa 58/2012 59/2012
otitis media 51/2014 52/2014
otosclerosis 119/2007 120/2007
Paget's disease of bone 19/2006 20/2006
panic disorder 68/2009 69/2009
Parkinson’s disease and parkinsonism 65/2007 66/2007
patellar tendinopathy 114/2011 115/2011
periodic limb movement disorder 26/2014 27/2014
periodontal abscess 49/2013 50/2013
periodontitis 47/2013 48/2013
peripheral neuropathy 74/2014 75/2014
peritoneal adhesions 103/2007 104/2007
personality disorder 70/2008 71/2008
pes planus 45/2012 46/2012
photocontact dermatitis 108/2011 109/2011
physical injury due to munitions discharge 48/2012 49/2012
pilonidal sinus 71/2010 72/2010
pinguecula 77/2007 78/2007
plantar fasciitis 19/2007 20/2007
pleural plaque 45/2014 46/2014
poisoning and toxic reaction from plants and fungi 84/2010 85/2010
polyarteritis nodosa 11/2011 12/2011
polycythaemia vera 11/2013 12/2013
polymyalgia rheumatica 23/2008 24/2008
porphyria cutanea tarda 43/2012 44/2012
posttraumatic stress disorder 82/2014 83/2014
presbyopia 117/2007 118/2007
primary myelofibrosis 17/2013 18/2013
psoriasis 31/2012 32/2012
psoriatic arthropathy 5/2012 6/2012
pterygium 75/2007 76/2007
pulmonary barotrauma 45/2006 46/2006
pulmonary thromboembolism 56/2012 57/2012
rapidly progressive crescentic glomerulonephritis 81/2010 82/2010
reactive arthritis 26/2010 27/2010
relapsing polychondritis 45/2008 46/2008
renal artery atherosclerotic disease 102/2011 103/2011
renal stone disease 65/2010 66/2010
restless legs syndrome 20/2014 21/2014
retinal vascular occlusive disease 83/2011 84/2011
rheumatic heart disease 19/2011 20/2011
rheumatoid arthritis 68/2008 69/2008
Ross River virus infection 90/2010 91/2010
rotator cuff syndrome 39/2006 40/2006
sarcoidosis 115/2007 116/2007
schistosomiasis 86/2010 87/2010
schizophrenia 15/2009 16/2009
scrub typhus 72/2009 73/2009
seborrhoeic dermatitis 13/2013 14/2013
seborrhoeic keratosis 31/2006 32/2006
sensorineural hearing loss 5/2011 6/2011
shin splints 49/2006 50/2006
sick sinus syndrome 15/2014 16/2014
sickle-cell disorder 43/2008 44/2008
sinus barotrauma 49/2010 50/2010
sinusitis 09/2010 10/2010
sleep apnoea 41/2013 42/2013
smallpox 31/2008 32/2008
soft tissue sarcoma 13/2006 14/2006
solar keratosis 73/2012 74/2012
somatic symptom disorder 24/2014 25/2014
spasmodic torticollis 21/2008 22/2008
spina bifida 61/2007 62/2007
spinal adhesive arachnoiditis 116/2011 117/2011
spondylolisthesis and spondylolysis 05/2006 06/2006
sprain and strain 94/2011 95/2011
steatohepatitis 79/2013 80/2013
strongyloidiasis 88/2010 89/2010
subarachnoid haemorrhage 67/2010 68/2010
subdural haematoma 33/2011 34/2011
substance use disorder 3/2009 4/2009
sudden unexplained death 57/2013 58/2013
suicide and attempted suicide 11/2010 12/2010
systemic lupus erythematosus 85/2007 86/2007
systemic sclerosis 64/2009 65/2009
tension-type headache 1/2010 2/2010
thoracic spondylosis 64/2014 65/2014
thromboangiitis obliterans 7/2009 8/2009
tinea of the skin 13/2004 14/2004
tinnitus 33/2012 34/2012
toxic maculopathy 39/2009 40/2009
trigeminal neuralgia 54/2009 55/2009
trigeminal neuropathy 29/2009 30/2009
tuberculosis 43/2007 44/2007
varicocele 3/2011 4/2011
varicose veins of the lower limb 120/2011 121/2011
vascular dementia 78/2014 79/2014
von Willebrand's disease 57/2007 58/2007
warts 70/2014 71/2014
Wilson's disease 07/2007 08/2007

Schedule 2
Rate of disablement pension

r 17

Level of whole-person impairment (%) Weekly payment rate ($)
5–7 10.85
8–12 21.70
13–17 32.54
18–22 43.39
23–25 54.24
26–30 65.09
31–32 75.93
33–37 86.78
38–41 97.63
42–47 108.48
48–49 119.32
50 130.17
51 141.02
52–54 151.87
55–57 162.71
58–61 173.56
62–66 184.41
67 195.26
68–74 206.10
75 216.95
76 227.80
77 238.65
78 249.49
79 260.34
80 271.19
81 292.88
82 314.58
83 336.27
84 357.97
85–100 381.83

 Michael Webster,
Clerk of the Executive Council.


Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 7 December 2014, prescribe various matters as part of the implementation of the Veterans’ Support Act 2014 (the Act). Most of the provisions of the Act come into force on 7 December 2014. Certain provisions of the Act, including provisions that relate to Scheme Two and to the veterans’ independence programme, are scheduled to come into force on 7 December 2015. It is anticipated that these regulations will be amended during 2015 to prescribe matters relating to Scheme Two and the veterans’ independence programme.

In summary, these regulations prescribe matters relating to—

  • the definition of treatment provider. Acupuncturists, audiologists, counsellors, and speech therapists who meet certain criteria are added for the purposes of the definition of treatment provider in section 7 of the Act (regulations 4 to 8):

  • presumptions and instruments that assist in determining whether a veteran’s injury, illness, or condition is service-related, including—

    • a list of paired organs, for the purposes of the presumption relating to paired organs contained in section 20 of the Act (regulation 9):

    • the conditions that must be treated as service-related if a veteran has been exposed to specified events during qualifying operational service at specified times, during specified periods, or on specified deployments. Certain conditions and illnesses are specified for veterans who were prisoners of war during World War II, for veterans who may have been exposed to nuclear radiation on certain deployments, for veterans who served in Vietnam, and for veterans who served in the Gulf War (regulations 10 to 14):

    • the statements of principles determined by the Australian Repatriation Medical Authority under the Veterans’ Entitlements Act 1986 (Aust) that apply in New Zealand for the purposes of the Act. Every statement of principles that is in effect in Australia at the commencement of these regulations will apply in New Zealand (regulation 15):

  • entitlements of veterans and other claimants, and related matters, including—

    • the annual indexation of certain entitlements to reflect increases in the Consumers Price Index (All Groups) published by Statistics New Zealand (regulation 16):

    • the rates of the disablement pension, surviving spouse or partner pension, and children’s pension (regulations 17 to 19):

    • the maximum rate of the dependant’s pension and the assessment of a dependant’s economic position for the purposes of determining the rate payable to the dependant (regulations 20 to 25):

    • the rates of children’s bursaries (regulation 26):

    • entitlement to, and rates of, weekly battery allowance for batteries used in hearing aids (regulations 27 and 28):

    • the maximum amount of motor vehicle grants, limits on the frequency of motor vehicle grants, and the criteria for determining whether to make a motor vehicle grant (regulations 29 to 33):

    • the retirement lump sum payment, including the amount of the payment and provisions relating to the asset threshold and the asset assessment under section 150 of the Act (regulations 34 to 39):

    • the payment of funeral expenses, including the maximum amounts payable for the expenses of a funeral and burial or cremation of a veteran and for the transport of a veteran’s body (regulations 40 and 41):

    • the rates of the veteran’s pension (regulation 42):

    • the amount of lump sum payments payable on the death of certain recipients of the veteran’s pension (regulations 43 and 44):

  • the procedure for appeals against review decisions (regulations 45 to 53):

  • the procedure of the Veterans’ Advisory Board and of the Veterans’ Health Advisory Panel, including provisions relating to meetings, the form of resolutions, and conflicts of interest (regulations 54 to 63):

  • treatment cards for veterans with service-related injuries, illnesses, or conditions for which Veterans’ Affairs New Zealand will pay or contribute towards the cost of treatment (regulations 64 to 70):

  • the revocation of certain legislative instruments made under the War Pensions Act 1954 and superseded by these regulations (regulation 71).

Regulatory impact statement

The New Zealand Defence Force produced a regulatory impact statement on 8 August 2014 to help inform the decisions taken by the Government relating to the contents of this instrument.

A copy of this regulatory impact statement can be found at—


Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 4 December 2014.

These regulations are administered by the New Zealand Defence Force.